Article
Melanoma: Cutaneous, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN - 1 Jun 2026
Swetter Susan M, Johnson Douglas, Albertini Mark R, Barker Christopher A, Bateni Sarah, Baumgartner Joel, Bhatia Shailender, Bichakjian Christopher, Boland Genevieve, Chandra Sunandana, Chen David, Chmielowski Bartosz, Choi Jacob, DiMaio Dominick, Dronca Roxana, Fleming Martin D, Galan Anjela, Guild Samantha, Hu-Lieskovan Siwen, Karakousis Giorgos, Kendra Kari, Kiuru Maija, Lange Julie R, Lanning Ryan, Logan Theodore, Materin Miguel, Nelson Kelly, Olson Daniel, Olszanski Anthony J, Ott Patrick A, Puzanov Igor, Rothermel Luke, Salama April K, Shannon Adrienne, Sharma Rohit, Singh Arun, Stacey Andrew, Tsai Katy, Wuthrick Evan, Xing Yan, McMillian Nicole, Espinosa Sara
Abstract excerpt
The NCCN Guidelines for Melanoma: Cutaneous provide strategies for the diagnosis, treatment, and follow-up of patients with cutaneous melanoma, which is among the most common cancers in the United States. The outcome of cutaneous melanoma is significantly influenced by stage at initial presentation. Generally, localized disease and smaller primary tumors have been associated with more favorable prognosis. Thus,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.